To some, the line dividing non-drug form drug products is vague and seemingly unreadable. Most companies go out of their way not to cross the line, in the hopes of not having to deal with the regulatory issues that come with marketing drug products. Yet, more and more often, as new claims come onto the market, the exact point at which your product becomes a drug and not a cosmetic comes into the picture as a critical consideration in product development and marketing.
Establishing the Dividing Line: Is Your Product a Drug?
November 4, 2011
Fill out my online form.
Most Popular in Claims/Labeling
- 1FDA Issues Warning Letter for Eyebrow/Eyelash Growth Product Claims
- 2U.S. FDA Issues 15 Warning Letters Over CBD Products
- 3Why We Will Never Be Free From “Free-From” Claims
- 4Back to Basics IV: Product Labeling, Manufacturing and Launch
- 5The INCI Name Game: A Commentary
- 6Into the Weeds: Walking the Regulatory Line of CBD in Cosmetics
- 7The EU Fragrance Allergens
- 8Big Win for Cosmetics: Court Closes Prop 65 Titanium Dioxide Case
- 9Net Contents of a Cosmetic: The ‘E’ Mark and Units of Measure
- 10'May Contain' Ingredient Disclosures
- U.S. FDA Issues 15 Warning Letters Over CBD Products
11/26/2019, Jessie Kern
- Beginner's Guide to Natural/Organic
2/5/2019, John I. Yablonski, Bio-Control Consultants, LLC, Park City, UT, and David R. Winne, Claims Support Group, LLC, Cold Spring, NY
- Back to Basics, Part II: Ensuring Product Safety
4/29/2019, Pascal Yvon, BioSciences Expansion, LLC, Newtown, PA U.S.
- The INCI Name Game: A Commentary
7/12/2019, Rachel Grabenhofer
- Proposed 'Natural Cosmetics Act' Gains Traction with Indies
11/6/2019, Rachel Grabenhofer